Role of the prefrontal cortex in altered hippocampal-accumbens synaptic plasticity in a developmental animal model of schizophrenia

Cerebral Cortex

Volumn 24, Issue 4, 2014, Pages 968-977

  Belujon, Pauline ^a   Patton, Mary H ^a   Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

dopamine; long term potentiation; nucleus accumbens; prefrontal cortex; schizophrenia

Indexed keywords

SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN REGION; CONTROLLED STUDY; HIPPOCAMPUS; NERVE CELL PLASTICITY; NONHUMAN; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOMOTOR ACTIVITY; RAT; SCHIZOPHRENIA; SENSORY NERVE CELL; SYNAPTIC TRANSMISSION;

DOPAMINE; LONG-TERM POTENTIATION; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; SCHIZOPHRENIA;

ANALYSIS OF VARIANCE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; MALE; METHYLAZOXYMETHANOL ACETATE; NEURAL PATHWAYS; NEURONAL PLASTICITY; NEURONS; NEUROTOXINS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; SYNAPSES;

EID: 84884231127     PISSN: 10473211     EISSN: 14602199     Source Type: Journal    
DOI: 10.1093/cercor/bhs380     Document Type: Article

References (46)

1. Akil M, Pierri JN, Whitehead RE, Edgar CL, Mohila C, Sampson AR, Lewis DA. 1999. Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. Am J Psychiatry. 156:1580-1589.
2. Belujon P, Grace AA. 2008. Critical role of the prefrontal cortex in the regulation of hippocampus-accumbens information flow. J Neuro-sci. 28:9797-9805.
3. Benes FM, Berretta S. 2001. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsycho-pharmacology. 25:1-27.
4. Flagstad P, Mork A, Glenthoj BY, van Beek J, Michael-Titus AT, Di-driksen M. 2004. Disruption of neurogenesis on gestational day 17 in the rat causes behavioral changes relevant to positive and negative schizophrenia symptoms and alters amphetamine-induced dopamine release in nucleus accumbens. Neuropsycho-pharmacology. 29:2052-2064.
5. Floresco SB, Blaha CD, Yang CR, Phillips AG. 2001. Modulation of hippocampal and amygdalar-evoked activity of nucleus accum-bens neurons by dopamine: cellular mechanisms of input selection. J Neurosci. 21:2851-2860.
6. Goto Y, Grace AA. 2005a. Dopamine-dependent interactions between limbic and prefrontal cortical plasticity in the nucleus accumbens: disruption by cocaine sensitization. Neuron. 47:255-266.
7. Goto Y, Grace AA. 2005b. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nat Neurosci. 8:805-812.
8. Goto Y, Grace AA. 2006. Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development. Biol Psychiatry. 60:1259-1267.
9. Grace AA. 2000. Gating of information flow within the limbic system and the pathophysiology of schizophrenia. Brain Res Brain Res Rev. 31:330-341.
10. Grace AA. 2012. Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia. Neuropharmacology. 62:1342-1348.
11. Grace AA, Floresco SB, Goto Y, Lodge DJ. 2007. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci. 30:220-227.
12. Gurden H, Takita M, Jay TM. 2000. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses in vivo. J Neurosci. 20: RC106.
13. Heckers S, Konradi C. 2002. Hippocampal neurons in schizophrenia. J Neural Transm. 109:891-905.
14. Heckers S, Rauch SL, Goff D, Savage CR, Schacter DL, Fischman AJ, Alpert NM. 1998. Impaired recruitment of the hippocampus during conscious recollection in schizophrenia. Nat Neurosci. 1:318-323.
15. Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S. 2012. The nature of dopamine dysfunction in schizophrenia and what this means for treatment: meta-analysis of imaging studies. Arch Gen Psychiatry. 69:776-786.
16. Huang YY, Simpson E, Kellendonk C, Kandel ER. 2004. Genetic evidence for the bidirectional modulation of synaptic plasticity in the prefrontal cortex by D1 receptors. Proc Natl Acad Sci USA. 101:3236-3241.
17. Kapur S. 2003. Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 160:13-23.
18. Kelley AE. 2004. Ventral striatal control of appetitive motivation: role in ingestive behavior and reward-related learning. Neurosci Biobe-hav Rev. 27:765-776.
19. Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Carpenter WT, McMahon R. 2006. Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology. 31:221-230.
20. Lavin A, Grace AA. 1998. Response of the ventral pallidal/mediodorsal thalamic system to antipsychotic drug administration: involvement of the prefrontal cortex. Neuropsychopharmacology. 18:352-363.
21. Lavin A, Moore HM, Grace AA. 2005. Prenatal disruption of neocortical development alters prefrontal cortical neuron responses to dopa-mine in adult rats. Neuropsychopharmacology. 30:1426-1435.
22. Lewis DA, Hashimoto T, Volk DW. 2005. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 6:312-324.
23. Lewis DA, Moghaddam B. 2006. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol. 63:1372-1376.
24. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RS. 1992. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry. 160:179-186.
25. Lipska BK, Jaskiw GE, Weinberger DR. 1993. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 9:67-75.
26. Lodge DJ, Behrens MM, Grace AA. 2009. A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia. J Neurosci. 29: 2344-2354.
27. Lodge DJ, Grace AA. 2007. Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia. J Neurosci. 27:11424-11430.
28. Lodge DJ, Grace AA. 2006. The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology. 31:1356-1361.
29. Malaspina D, Storer S, Furman V, Esser P, Printz D, Berman A, Lignelli A, Gorman J, Van Heertum R. 1999. SPECT study of visual fixation in schizophrenia and comparison subjects. Biol Psychiatry. 46: 89-93.
30. Medoff DR, Holcomb HH, Lahti AC, Tamminga CA. 2001. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus. 11:543-550.
31. Mogenson GJ, Yang CR, Yim CY. 1988. Influence of dopamine on limbic inputs to the nucleus accumbens. Ann N Y Acad Sci. 537:86-100.
32. Molina V, Reig S, Pascau J, Sanz J, Sarramea F, Gispert JD, Luque R, Benito C, Palomo T, Desco M. 2003. Anatomical and functional cerebral variables associated with basal symptoms but not risper-idone response in minimally treated schizophrenia. Psychiatry Res. 124:163-175.
33. Molina V, Sanz J, Sarramea F, Benito C, Palomo T. 2005. Prefrontal atrophy in first episodes of schizophrenia associated with limbic metabolic hyperactivity. J Psychiatr Res. 39:117-127.
34. Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA. 2006. A neu-robehavioral systems analysis of adult rats exposed to methylazox-ymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiatry. 60:253-264.
35. Moore H, West AR, Grace AA. 1999. The regulation of forebrain dopa-mine transmission: relevance to the pathophysiology and psycho-pathology of schizophrenia. Biol Psychiatry. 46:40-55.
36. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. 1998. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry. 55:433-440.
37. O'Donnell P, Grace AA. 1998. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr Bull. 24:267-283.
38. O'Donnell P, Greene J, Pabello N, Lewis BL, Grace AA. 1999. Modulation of cell firing in the nucleus accumbens. Ann N Y Acad Sci. 877:157-175.
39. O'Donnell P, Lewis BL, Weinberger DR, Lipska BK. 2002. Neonatal hippocampal damage alters electrophysiological properties of pre-frontal cortical neurons in adult rats. Cereb Cortex. 12:975-982.
40. Paxinos G, Watson C. 1996. The rat brain in stereotaxic coordinates. San Diego: Academic Press.
41. Sesack SR, Grace AA. 2010. Cortico-Basal Ganglia reward network: microcircuitry. Neuropsychopharmacology. 35:27-47.
42. Silbersweig DA, Stern E, Frith C, Cahill C, Holmes A, Grootoonk S, Seaward J, McKenna P, Chua SE, Schnorr L et al. 1995. A functional neuroanatomy of hallucinations in schizophrenia. Nature. 378:176-179.
43. Smith SE, Li J, Garbett K, Mirnics K, Patterson PH. 2007. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci. 27:10695-10702.
44. Tseng KY, Amin F, Lewis BL, O'Donnell P. 2006. Altered prefrontal cortical metabolic response to mesocortical activation in adult animals with a neonatal ventral hippocampal lesion. Biol Psychiatry. 60:585-590.
45. Tseng KY, Lewis BL, Lipska BK, O'Donnell P. 2007. Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia. Biol Psychiatry. 62:730-738.
46. Weiss AP, Goff D, Schacter DL, Ditman T, Freudenreich O, Henderson D, Heckers S. 2006. Fronto-hippocampal function during temporal context monitoring in schizophrenia. Biol Psychiatry. 60: 1268-1277.